MTLS
Materialise N.V.
MTLS
Materialise N.V.
Materialise's Medical continues to deliver double-digit growth and strong margins and is increasingly underpinning the company's value. The Manufacturing segment is recovering, with aerospace strength
Materialise (NASDAQ: MTLS) reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in
While Materialise's Q1 results were soft, its Medical segment appears to be stabilizing and the software business model transition is nearing completion. Cost discipline and a return to growth should